Novogen Settles Patent Spat Over Menopause Patents
Novogen announced Tuesday that it had settled a lawsuit filed against Tennessee-based health products maker Chattem Inc. for allegedly violating two patents for supplements containing isoflavones, which have been found to reduce such menopause symptoms as hot flashes. Terms of the settlement were not disclosed.
Novogen filed the lawsuit in March 2006, accusing Chattem of infringement through the sale of...
To view the full article, register now.